Allogeneic CRISPR CAR-T Cell Therapy Hub Model

Underwrite universal donor TCR-knockout allogeneic CRISPR-edited CAR-T cell manufacturing cleanrooms (producing 5,000 patient infusion doses/year from single healthy donors). Model clinical off-take ($45,000/dose vs $400k autologous), and 20-yr IRR.